Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
Black patients are already less likely to receive LVADs or transplants compared to whites, and these inaccurate readings can further widen the disparities.